Search research articles
Contact Us
Filters
Showing results (211-220 of 436) with videos related to
Page
of 44
Sort By:
International Journal of Hematology
|
March 5, 2019
Incidence of second malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors
Koji Sasaki, Hagop M Kantarjian, Susan O'Brien, et al.
Leukemia & Lymphoma
|
November 10, 2017
Myeloid/lymphoid neoplasms with FGFR1 rearrangement
Paolo Strati, Guilin Tang, Dzifa Y Duose, et al.
Journal of Hematology & Oncology
|
January 5, 2019
Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience
Kamal Chamoun, Hagop Kantarjian, Rami Atallah, et al.
American Journal of Hematology
|
November 28, 2017
Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression
Elias Jabbour, Johannes Düll, Musa Yilmaz, et al.
Leukemia
|
September 5, 2025
Impact of discordant revised versus molecular international prognostic scoring system risk in myelodysplastic syndrome
Alexandre Bazinet, Guillermo Montalban-Bravo, Alex Bataller, et al.
Leukemia
|
March 28, 2023
Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1
Christopher P Mill, Warren Fiskus, Kaberi Das, et al.
Cancer
|
September 23, 2016
Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemia
Farhad Ravandi, Jeffrey Jorgensen, Gautam Borthakur, et al.
Blood
|
January 6, 2016
Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors
Preetesh Jain, Hagop Kantarjian, Keyur P Patel, et al.
Blood Cancer Journal
|
March 18, 2021
Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study
Patrick K Reville, Hagop M Kantarjian, Farhad Ravandi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 29, 2023
Immunologic Predictors for Clinical Responses during Immune Checkpoint Blockade in Patients with Myelodysplastic Syndromes
Sung-Eun Lee, Feng Wang, Maison Grefe, et al.
Page
of 44
Search research articles
Search
Showing results (211-220 of 436) with videos related to
Sort By:
Page
of 44
International Journal of Hematology
|
March 5, 2019
Incidence of second malignancies in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitors
Koji Sasaki, Hagop M Kantarjian, Susan O'Brien, et al.
Leukemia & Lymphoma
|
November 10, 2017
Myeloid/lymphoid neoplasms with FGFR1 rearrangement
Paolo Strati, Guilin Tang, Dzifa Y Duose, et al.
Journal of Hematology & Oncology
|
January 5, 2019
Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience
Kamal Chamoun, Hagop Kantarjian, Rami Atallah, et al.
American Journal of Hematology
|
November 28, 2017
Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression
Elias Jabbour, Johannes Düll, Musa Yilmaz, et al.
Leukemia
|
September 5, 2025
Impact of discordant revised versus molecular international prognostic scoring system risk in myelodysplastic syndrome
Alexandre Bazinet, Guillermo Montalban-Bravo, Alex Bataller, et al.
Leukemia
|
March 28, 2023
Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1
Christopher P Mill, Warren Fiskus, Kaberi Das, et al.
Cancer
|
September 23, 2016
Persistence of minimal residual disease assessed by multiparameter flow cytometry is highly prognostic in younger patients with acute myeloid leukemia
Farhad Ravandi, Jeffrey Jorgensen, Gautam Borthakur, et al.
Blood
|
January 6, 2016
Impact of BCR-ABL transcript type on outcome in patients with chronic-phase CML treated with tyrosine kinase inhibitors
Preetesh Jain, Hagop Kantarjian, Keyur P Patel, et al.
Blood Cancer Journal
|
March 18, 2021
Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study
Patrick K Reville, Hagop M Kantarjian, Farhad Ravandi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 29, 2023
Immunologic Predictors for Clinical Responses during Immune Checkpoint Blockade in Patients with Myelodysplastic Syndromes
Sung-Eun Lee, Feng Wang, Maison Grefe, et al.
Page
of 44